These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31075744)

  • 1. Nimesulide analogues: From anti-inflammatory to antitumor agents.
    Catarro M; Serrano JL; Ramos SS; Silvestre S; Almeida P
    Bioorg Chem; 2019 Jul; 88():102966. PubMed ID: 31075744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New nimesulide derivatives with amide/sulfonamide moieties: Selective COX-2 inhibition and antitumor effects.
    Güngör T; Ozleyen A; Yılmaz YB; Siyah P; Ay M; Durdağı S; Tumer TB
    Eur J Med Chem; 2021 Oct; 221():113566. PubMed ID: 34077833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relatively selective cyclooxygenase-2 inhibitor nimesulide: What's going on?
    Caiazzo E; Ialenti A; Cicala C
    Eur J Pharmacol; 2019 Apr; 848():105-111. PubMed ID: 30689999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of a biotinylated probe of COX-2 inhibitor nimesulide analog JCC76.
    Zhong B; Lama R; Smith KM; Xu Y; Su B
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5324-7. PubMed ID: 21807508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lead optimization of COX-2 inhibitor nimesulide analogs to overcome aromatase inhibitor resistance in breast cancer cells.
    Su B; Chen S
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6733-5. PubMed ID: 19854050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developments in synthesis of the anti-inflammatory drug, celecoxib: a review.
    Kumar V; Kaur K; Gupta GK; Gupta AK; Kumar S
    Recent Pat Inflamm Allergy Drug Discov; 2013 May; 7(2):124-34. PubMed ID: 23565678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors.
    Taher ES; Ibrahim TS; Fares M; Al-Mahmoudy AMM; Radwan AF; Orabi KY; El-Sabbagh OI
    Eur J Med Chem; 2019 Jun; 171():372-382. PubMed ID: 30928709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coumarin Derivatives as Anti-inflammatory and Anticancer Agents.
    Thomas V; Giles D; Basavarajaswamy GPM; Das AK; Patel A
    Anticancer Agents Med Chem; 2017; 17(3):415-423. PubMed ID: 27592545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Evaluation of Nimesulide-Loaded Nanoparticles for Anticancer Activity Against Breast Cancer Cells.
    Sengel-Turk CT; Hascicek C; Bakar F; Simsek E
    AAPS PharmSciTech; 2017 Feb; 18(2):393-403. PubMed ID: 27007742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo pharmacological evidence of selective cyclooxygenase-2 inhibition by nimesulide: an overview.
    Famaey JP
    Inflamm Res; 1997 Nov; 46(11):437-46. PubMed ID: 9427063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From COX-2 inhibitor nimesulide to potent anti-cancer agent: synthesis, in vitro, in vivo and pharmacokinetic evaluation.
    Zhong B; Cai X; Chennamaneni S; Yi X; Liu L; Pink JJ; Dowlati A; Xu Y; Zhou A; Su B
    Eur J Med Chem; 2012 Jan; 47(1):432-444. PubMed ID: 22119125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylene-bearing sulfur-containing cyanopyrimidine derivatives for treatment of cancer: Part-II.
    Akhtar W; Nainwal LM; Kaushik SK; Akhtar M; Shaquiquzzaman M; Almalki F; Saifullah K; Marella A; Alam MM
    Arch Pharm (Weinheim); 2020 May; 353(5):e1900333. PubMed ID: 32115728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel (pyrazolyl)benzenesulfonamides with a nitric oxide-releasing moiety as selective cyclooxygenase-2 inhibitors.
    Bechmann N; Kniess T; Köckerling M; Pigorsch A; Steinbach J; Pietzsch J
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3295-300. PubMed ID: 26081289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Thiourea Derivatives Bearing Sulfonamide Moiety as Anticancer Agents Through COX-2 Inhibition.
    Ghorab MM; El-Gaby MSA; Alsaid MS; Elshaier YAMM; Soliman AM; El-Senduny FF; Badria FA; Sherif AYA
    Anticancer Agents Med Chem; 2017; 17(10):1411-1425. PubMed ID: 28356021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives.
    Abdellatif KR; Fadaly WA; Ali WA; Kamel GM
    J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coumarins scaffolds as COX inhibitors.
    Revankar HM; Bukhari SN; Kumar GB; Qin HL
    Bioorg Chem; 2017 Apr; 71():146-159. PubMed ID: 28222891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, anti-inflammatory, cytotoxic, and COX-1/2 inhibitory activities of cyclic imides bearing 3-benzenesulfonamide, oxime, and β-phenylalanine scaffolds: a molecular docking study.
    Abdel-Aziz AA; El-Azab AS; AlSaif NA; Alanazi MM; El-Gendy MA; Obaidullah AJ; Alkahtani HM; Almehizia AA; Al-Suwaidan IA
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):610-621. PubMed ID: 32013633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety.
    Sağlık BN; Osmaniye D; Levent S; Çevik UA; Çavuşoğlu BK; Özkay Y; Kaplancıklı ZA
    Eur J Med Chem; 2021 Jan; 209():112918. PubMed ID: 33071054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic enaminone as new chemotype for selective cyclooxygenase-2 inhibitory, anti-inflammatory, and analgesic activities.
    Kumar R; Saha N; Purohit P; Garg SK; Seth K; Meena VS; Dubey S; Dave K; Goyal R; Sharma SS; Banerjee UC; Chakraborti AK
    Eur J Med Chem; 2019 Nov; 182():111601. PubMed ID: 31445233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.